Search results
-
Dr Gill Barnett
Increased understanding of the genetic basis for the wide variation between patients in the severity of late radiotherapy toxicity.
-
Professor Grant Stewart
Professor Stewart is an academic surgeon at the University of Cambridge, with a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising management of patients with...
-
Professor George Vassiliou
I am a CR-UK Senior Clinical Fellow and a member of Faculty at the Wellcome Sanger and Wellcome-MRC Cambridge Stem Cell Institutes. My group is studying the pre-clinical evolution, pathogenesis and treatment of haematological malignancies with a...
-
Mr Harveer Dev
I am a CRUK Clinical Lecturer in the Early Detection Programme, and Honorary Speciality Registrar in Urology, with a research interest in genome stability and prostate cancer. ...
-
Professor Heike Laman
F-box proteins (FBPs) are the substrate-recruiting subunits of SCF (Skp1-cullin1-FBP)-type E3 ubiquitin ligases, but ubiquitinated substrates have been identified for only a few of the sixty-nine FBPs identified in humans. The major aim of my laboratory...
-
Professor Helena Earl
Clinical and Translational Research in Breast and Gynaecological Cancers with the Aim of Individualising Cancer Treatments for Patients.
-
Dr Kelly Holmes
Kelly Holmes, PhD, CRUK Cambridge Centre Imaging Programme Manager. Kelly has a first class degree in Biochemistry with a year in industry. She completed her PhD on epigenetic regulation in embryonic development at The Babraham Institute. Wanting to...
-
Mr Isaac Toleman
... better models for kidney cancer immunotherapy using patient-tissues to predict patient-responses. My bachelors degree was "BSc Biochemistry with Study in ...
-
Dr James Tysome
Angiogenesis plays a role in the growth of many skull base and head and neck tumours. I aim to investigate the role of angiogenesis inhibitors in these tumours, develop novel inhibitors including oncolytic viruses and use molecular imaging techniques to...
-
Dr James Nathan
Cellular mechanisms of oxygen and metabolite sensing: ...
-
Dr Ashray Gunjur
I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...
-
Mr Aman Coonar
... PI for PULMICC study- a RCT of metastectomy v best other care for colorectal metastases to lung. ...
-
Dr Anny Wong
... and investigations. She also specialises in the follow-up care of children who have finished their cancer treatment. ...
-
Dr Catherine Green
I run a small group in the Department of Zoology funded by a Cancer Research UK career development fellowship. We are investigating the mechanisms and control of genome replication, both at genetic and epigenetic levels. It is during replication that...
-
Professor Fiona Gilbert
... radiotracers which may be valuable as biomarkers for patient care or in drug development. ...
-
Dr Helen Morris
In the Primary Care Unit I've managed and collaborated on a number of randomised controlled ... studies in the field of cancer and genetics in a primary care setting: 1) The GRAIDS (Genetic Risk Assessment on the Internet and ... the management of suspicious pigmented lesions in primary care, CI Dr F Walter; 3) BEST (Barrett's Oesophagus Screening Trial), CI Dr R ...
-
Professor James Brenton
Ovarian cancer has a disproportionately high health care burden because of low cure rates and frequent symptoms caused by recurrent ...
-
Dr Juliet Usher-Smith
My research focuses on the use of risk prediction models to promote behaviour change to help prevent cancer and inform stratified screening programmes.
-
Dr Kelly Fagan Robinson
... hierarchies, education, and experiences of formalised care can generate epistemic dissonances and injustices for British people. ... populations within the contexts of cancer, risk and care. This project has facilitated greater understanding of various ...
-
Dr Kyren Lazarus
My overall career ambition is to develop novel insights into breast cancer pathology to help improve clinical outcomes for sufferers. I will be working with Dr Walid Khaled in order to understand transcriptional regulation of cell fate in mammary...
-
Dr Ashwin Seshia
... microelectromechanical and microfluidics based platforms for early diagnosis. We also research microfabricated biophysical tools to ...
-
Dr Annalise Katz-Summercorn
Early detection in oesophageal adenocarcinoma
-
Dr Aisling Redmond
... MRC Cancer Unit in Cambridge. The Fitzgerald group focus on early detection of Oesophageal cancer and have pioneered the CytospongeTM ...
-
Mr Amit Roshan
... of Surgeons Clinician Scientist with a clinical interest in early stage melanoma. My research focus is currently exploring the utility of circulating tumour DNA (ctDNA) in early melanoma, and progressing our understanding of disease mechanisms in the ...
-
Dr Andre Neves
... am interested in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. ...
-
Professor Bertie Gottgens
... Current research focuses on (i) single cell genomics of early blood development, (ii) computer models to chart the transcriptional ...
-
Mrs Barbara Newcombe
... BRCA1&2 mutation tested, male and female 2. SLN technique in early Vulval cancer 3. randomised surgical intervention for early cervix cancer ...
-
Professor Kevin Brindle
... resonance-based molecular imaging techniques to detect the early responses of tumours to therapy, with a view to translating these into ... responses to an anti-vascular drug and for detecting early tumour responses to immunotherapy. An early apoptotic response following ...
-
Dr Bristi Basu
... Research Committee member; Eastern Lead for NIHR CRN Early Phase Cancer Studies Specialty Group. My research focus is in drug ... translate preclinical findings on lead candidate agents into early phase clinical trials of novel therapeutic drugs as chief investigator, ...
-
Dr Brent O'Carrigan
- Phase 2/3 clinical trials in renal cancer and melanoma ...
-
Professor Charlotte Coles
... with linked translational research: 1. IMPORT LOW : phase III randomised trial (RCT) investigating intensity modulated radiotherapy ... 2018 patients recruited; 71 UK centres 2. IMPORT HIGH : phase III RCT investigating dose-escalated IMRT for patients at higher risk of ...
-
Dr Pippa Corrie
... I am chief investigator of the national adjuvant melanoma phase 3 trial, collaborating with Mark Middleton, Oxford, who leads associated ...
-
Professor Tim Eisen
... responsible for oncology trials from first in man to Phase II. ...
-
Dr Hugo Ford
... and gastric cancer. I am chief investigator of a national phase 3 trial of gastric cancer chemotherapy and locally am collaborating with ...
-
Dr Gaia Schiavon
- Use of ctDNA analysis for early assessment of response / prediction of long term outcome, and to interrogate minimal residual disease ...
-
Professor Duncan Jodrell
... novel therapeutic combinations, including first into man (phase I) and associated studies. My research goal is to identify successful, ...
-
Professor Antonis Antoniou
... of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. I have a research group of 10 which focuses on two broad ...
-
Dr Alasdair Russell
... to complex, patient-relevant model systems in a pre-clinical setting. Further, we use these novel models in a range of pre-clinical trials to advance our understanding of disease. ...
-
Dr Amos Burke
... a member of the National Cancer Research Institute Lymphoma Clinical Studies Group and chairs its paediatric Non-Hodgkin Lymphoma subgroup. ... laboratory collaborations and currently co-supervises a Clinical and a basic science PhD student. At a national level Dr Burke is the ...
-
Dr Andrew Pierce
DNA damage and repair, oncology clinical biomarkers ...
-
Dr Andrew Gee
Since 1995, I have been working on technical aspects of clinical ultrasonic imaging, with particular emphasis on three-dimensional ...
-
Mr Angelos Kolias
Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, ... Neurology and Neurosurgery, Queen Square, London. His clinical interests include surgery for brain tumours (special interest in skull ...
-
Dr Anna Piskorz
... Molecular Diagnostic Laboratory. I’m engaged in several clinical trails (ARIEL2, PISSARO, ICON7, ICON8, MADCaP, PHL-093 Toronto, ...
-
Professor Anthony Davenport
... through membership of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug ...
-
Dr Basma Greef
... develop new treatments. My other interests include clinical trials and the effective management of toxicities related to widely used ...
-
Ms Ceilidh Welsh
... from nearly 3000 patients recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...
-
Dr Danish Mazhar
... He is the Principal Investigator of numerous clinical trials in Prostate, Bladder and Testis Cancers. He is a member of National ...
-
Dr David Gilligan
... tract cancer and is an enthusiastic participator in clinical trials. He has been a member of the NCRI Lung Cancer Studies Group. He is ...
-
Cambridge Cancer Trials Centre
... Trials Unit - Cancer Theme (CCTU-CT). If you are a patient and want to know more about clinical trials trials relevant to you, ... the Clinical Operations Team, which is responsible for the care of the patient taking part, or thinking about taking part in clinical ...
-
Putting patients first
... patients each year providing the highest quality clinical care backed up by some of the finest cancer science in the world. The 5 year ... Papworth Hospital) where innovative research is improving patient diagnosis and treatment. Late phase ...
-
World Pancreatic Cancer Day: The role of research nurses in clinical trials
... to ensure they meet the trials requirements. Once the patient is deemed eligible we then coordinate their care, recording data relating to treatment they are having and side effects. We ...
-
Clinical research on lung cancer
... helps over 500 patients every year. The interests of the patient are always the top priority. We offer patients the best routine care. Whenever possible, we also offer patients the opportunity to take part in ...
-
Clinical research on breast cancer
... different breast cancer types, which will then enable each patient to be given the most effective course of treatment. Cambridge is also ... being introduced into more UK centres as a standard of care. Response to hormone therapy We have identified how the oestrogen ...
-
NIHR Cambridge Biomedical Research Centre (BRC)
... burden, amounting in the UK to ~£16bn/year in health care, economic and other costs. Therefore, the overarching goal of the Cancer ... device allowing novel integration of fusion imaging with out-patient local anaesthetic perineal biopsy for prostate cancer; and a study to ...
-
Major funding for Cambridge Experimental Cancer Medicine Centre
... Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Little Princess Trust specifically for ... to all our research teams working in alliance with our patient and public involvement group, and our academic and industrial partners. ...
-
New trial brings screening for oesophageal cancer closer
... Cancer Research UK and the National Institute for Health and Care Research. Tim Cowper, 49, a brewer from Cambridge, has had acid ... to swallow capsule on a thread, which contains a sponge. The patient swallows the capsule which dissolves in the stomach and the sponge ...
